Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen is designed to deliver exactly four weekly doses of tirzepatide. You cannot safely extract an extra dose from a pen that has reached its final injection, and attempting to do so risks an inaccurate amount of medicine, a contaminated needle, or no medicine at all. Here is what the device actually contains, why the question arises, and what to do instead — all based on the pen's licensed design. Like all prescription-only medicines, Mounjaro must be prescribed following a clinical assessment; a prescriber decides the dose that is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks goes something like this: "There's still a bit of liquid left after my fourth injection, can I use it?" It is a completely understandable thing to notice. When you deliver the fourth dose and remove the pen, a small amount of liquid remains visible in the cartridge. The pen does not feel empty.
That residual liquid is overfill, deliberately included by Eli Lilly during manufacture to guarantee that each of the four labelled doses is complete and accurate. Medical device regulators expect injectable pens to carry this buffer; it is standard practice, not a bonus supply. The Mounjaro SmPC on the eMC confirms the pen delivers four doses; nothing in the licensed documentation describes a fifth. The overfill is not in a usable, measurable, sterile state once the four doses have been drawn down through the pen's mechanism.
Beyond the residual-liquid question, some people try to draw a fifth dose by attaching a fresh needle and pressing the plunger manually, and if you are curious about getting an extra dose out of Mounjaro this way, it is worth understanding why the approach does not work. The KwikPen's auto-injection mechanism is not designed for this. You are unlikely to get a consistent volume, you risk introducing contamination through repeated needle attachment, and the plunger stop exists for a reason. The result would be an unknown quantity of medicine, not a clinically meaningful dose of tirzepatide.
Not reliably, no. The cartridge is not a graduated measuring vessel. Liquid levels shift depending on how the pen is stored (lying flat versus upright), temperature, and whether air bubbles are present. Judging remaining doses by the fluid line is the kind of shortcut that looks logical but is not accurate enough for a prescription medicine.
The safer habit is to count your injections. Each pen delivers four weekly doses. If you started a new pen four weeks ago, it is finished. Some people keep a simple record on their phone or mark the date of the first injection on the pen itself with a marker, small practical steps that remove the guesswork entirely. Our Mounjaro dosage guide walks through the titration schedule and how to track where you are in your treatment.
Storage conditions matter here too. Mounjaro pens should be kept refrigerated at 2–8°C. A pen that has been stored outside those conditions, or carried at room temperature beyond the window stated in the Patient Information Leaflet, may not deliver medicine that is still fully effective, another reason liquid appearance alone tells you very little. For exact storage guidance, the leaflet inside your pen box is the authoritative source. It is also worth knowing that if your Mounjaro pen appears to have an extra dose based on the fluid level, that appearance is explained by the overfill buffer rather than any additional supply.
This is the practical problem behind most "extra dose" searches. The pen is done, the next one has not arrived, and the weekly injection window is approaching. There are a few options worth knowing.
First, a short delay of a day or two is unlikely to be clinically significant for most people, but you should confirm this with your prescriber rather than assume it. The NHS medicines guidance for tirzepatide, available at nhs.uk/medicines/tirzepatide, notes that missed dose advice should come from your healthcare team. Do not attempt to extend the pen.
Second, plan supply so that a gap does not arise. At nume, orders placed before 12pm on a working day are reviewed by a GPhC-registered prescriber and, if clinically suitable, dispatched the same afternoon by DPD for next-working-day delivery. That predictable turnaround means you can time your repeat order so the next pen arrives before the current one finishes. If you are transferring from another provider or have a supply question, our team is reachable through our contact page.
Third, if you are wondering whether a different dose strength or a change in your schedule would suit you better, that is a conversation for your prescriber at your next clinical review, not a problem to solve by rationing individual pens. For a broader look at how Mounjaro fits into a weight-management plan, our treatment overview covers the context.
In practical terms, yes, though not a dramatic one. The risks are not exotic. Attaching a fresh needle to a pen that has delivered its four doses and attempting a manual injection may result in: no medicine being delivered (so you miss your dose entirely); an air-shot that introduces bubbles to the injection site; or a very small, inconsistent volume that does not represent a therapeutic amount of tirzepatide at any licensed dose strength. Our page on Mounjaro extra dose explains in more detail why none of these outcomes constitute a real additional dose.
None of these outcomes are helpful. The more significant risk is the knock-on effect: if you believe you have taken a dose and have not, your appetite suppression and blood-glucose response will be absent that week, without you realising why. That uncertainty is worth avoiding. Some users also ask whether you can get 5 doses out of a Mounjaro pen, and the answer, for all the reasons above, is no. Tirzepatide is a dual GIP and GLP-1 receptor agonist whose effect depends on consistent weekly dosing; consistency matters more than squeezing the last drop from a cartridge.
If you have questions about your current pen, a dose you may have missed, or what to expect at your next titration step, the right route is your prescriber or the Patient Information Leaflet. You can also review common questions on our FAQ page. For those who have not yet started treatment and want to understand whether Mounjaro is clinically appropriate for them, starting a free consultation is the place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.